Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • bad quality of Read2 using a MiSeq ReagenKit v2

    Hello all,

    is there someone else who uses the MiSeq Reagent Kit v2 with 2x251 cycles? I already started several runs for an amplicon-panel on the MiSeq and always the same problem occured: after 150 cycles in Read1 the Q<30 value rapidly decreases, however the average of Q<30 after Read1 is about 70-80% (Cluster Density (K/mm2) of 930+/-20), which seems to be okay. But the Q<30 for Read2 only starts at 50% and ends at about 30%. This results in bad sequences for Read2 with lower coverages and more dropouts and uncompleted regions. We already considered several issues that may cause this problem.

    - The chemistry of the kit or a defective laser can't be the reason, because the Index-Read (containing 6 bases) which occurs directly after Read1 shows good results and a Q<30 of 98%.

    - Another idea was that after a certain time our amplicons can't resist the mechanical pressure on the flow cell because of the wash steps etc. so that they break and consequently only areas situated on the flow cell basis could be read.

    - Or is there something wrong with the instrument? a possibilitie in this case could be to ask Illumina for a prepared template. When all cycles (2x251) normally work, we can be sure, that the issue comes from our library preparation.

    -Another point is the problem of low diversity that is common in amplicon sequencing: Actually our PhiX spike in was 25%, perhaps we have to increase the content to 50%... and to reduce the
    cluster density by inserting less than 2nM (we actually add) from the library). We already designed modifications upstream of the primers to garantee more variation.

    Perhaps this problem is not unknown and it happens to someone... I'm happy about each advice or idea,

    thanks a lot in advance!

  • #2
    Are you running the latest version of RTA on your MiSeq? That should deal with any problems arising from low diversity. And have you talked to Illumina tech support?

    Comment


    • #3
      What you're quoting for Read 1 sounds pretty normal to me, especially with amplicons. Read 2 will always be worse than Read 1, but the values you're giving are worse than what should be expected.

      Have you looked to see if there is a marked difference in your metrics for the top and bottom flow-cell planes? If you're concern is that only one side of the flow-cell is being maintained/sequenced, then seeing if the metrics between the two planes would easily tell you if there really is an issue.

      Another suggestion would be to try a phiX run to ensure that there really are no problems with your instrument.

      As far as the low diversity goes, assuming you're system is updated you should be running the latest version of RTA, which deals with base skew pretty well. However, you are clustered above what Illumina would recommend, so try dropping your target value down to around 650 and try again. Lowering the cluster density to around that point should solve most low-diversity issues, assuming you're working with the latest RTA version.

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Essential Discoveries and Tools in Epitranscriptomics
        by seqadmin




        The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...
        Yesterday, 07:01 AM
      • seqadmin
        Current Approaches to Protein Sequencing
        by seqadmin


        Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
        04-04-2024, 04:25 PM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, 04-11-2024, 12:08 PM
      0 responses
      57 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-10-2024, 10:19 PM
      0 responses
      53 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-10-2024, 09:21 AM
      0 responses
      45 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-04-2024, 09:00 AM
      0 responses
      55 views
      0 likes
      Last Post seqadmin  
      Working...
      X